Urgent research needed to determine most effective follow-up care for lung cancer patients

Scientist say there is an urgent need for research into all aspects of follow-up care in lung cancer. The study presented in the May 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology focused on different follow-up strategies for patients with lung cancer. After searching the published literature and databases, researchers analyzed four studies and could not determine that one method was preferred over another.

"Thus it is clear that more prospective research is needed in this area, ideally in the form of well-designed randomized controlled trials comparing different follow up strategies in patients who have received treatment for lung cancer," the study says.

What researchers were able to conclude is that, "regular follow-up results in fewer crisis driven health related episodes." They also note that in a previous study evidence showed that, "follow-up led by specialty clinical nurses is associated with high levels of and acceptability and with comparable levels of quality of life, median survival and time to progression."

Dr. David Baldwin and Dr. Mia Schmidt-Hansen, co-authors of the study, explain that the reason this research is so needed is because patients who have developed a primary lung cancer are at increased risk of developing a second primary lung cancer because they have a field effect of exposure to their lungs and may have some as well. Furthermore, they say, patients who have had lung cancer and have had treatment for cure and no evidence of , have a significant risk of local recurrence and that can take months to years to manifest. While surveillance after therapy for cure makes a lot of and there are data to support it, balancing the of repeated CT scans and the relative costs versus benefit is the real issue.

In the absence of firm evidence, the authors recommend the advice from the guidelines in the National Institute for Health and Clinical Excellence:

  • Offer all patients an initial specialist follow-up appointment within 6 weeks of completing treatment to discuss ongoing care, and regular appointments thereafter rather than relying on patients requesting appointments when they experience symptoms.
  • Offer protocol-driven follow up led by a lung cancer clinical nurse specialist as an option for patients with a life expectancy of more than 3 months.
  • Ensure that patients know how to contact the lung cancer clinical nurse specialist involved in their care between their scheduled hospital visits.
The lead author of this work is Dr. Mia Schmidt-Hansen. Dr. David Baldwin is an IASLC member co-author.

Provided by International Association for the Study of Lung Cancer

5 /5 (2 votes)
add to favorites email to friend print save as pdf

Related Stories

Lung cancer patients with diabetes show prolonged survival

Oct 17, 2011

Lung cancer patients with diabetes tend to live longer than patients without diabetes, according to a Norwegian study published in the November issue of the Journal of Thoracic Oncology, the official publication of the International ...

Recommended for you

Gene test aids cancer profile

6 hours ago

The first round of chemotherapy did little to suppress Ron Bose's leukemia. The second round, with 10 times the dose, knocked the proliferating blast cells down, but only by half.

How a common antacid could lead to cheaper anti-cancer drugs

23 hours ago

A popular indigestion medication can increase survival in colorectal cancer, according to research published in ecancermedicalscience. But in fact, scientists have studied this for years - and a group of cancer advocates want t ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.